---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-002295"
form_type: "8-K"
ticker: "NTHI"
cik: "0001979414"
company_name: "NEONC TECHNOLOGIES HOLDINGS, INC."
filed_at: "2025-04-01T23:59:59+00:00"
generated_at: "2026-05-24T01:10:43.645681+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NeOnc raises $1.6M placement; partners CBCC for India GBM trial

## Summary
- Private placement gross proceeds ~$1.6M at $16/share for working capital.
- Strategic partnership with CBCC Global Research to enroll patients at 30 FDA-compliant sites in India.
- Partnership targets Phase 2a NEO100-01 GBM trial; enrollment completion expected this year, readout 6-8 months after.
- Financing is unregistered under Rule 506(b) to accredited investors.

## SEC filing metadata
- accession: 0001829126-25-002295
- form_type: 8-K
- ticker: NTHI
- cik: 0001979414
- company_name: NEONC TECHNOLOGIES HOLDINGS, INC.
- filed_at: 2025-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/0001829126-25-002295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/neonctechnologies_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-002295
- JSON: https://secwatch.observer/filing/0001829126-25-002295.json
- Plain text: https://secwatch.observer/filing/0001829126-25-002295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.